Special Reports Enforcement Actions Reveal What Pharmacies Need To Know About DEA Requirements Top 10 Recent FDA & DEA Developments — And What's Next in 2025 Top 10 Recent FDA & DEA Developments — And What's Next in 2024 DEA Enforcement Update: DEA, DOJ Continue To Target Pharmacies for Noncompliance Seven Simple Ways to Detect and Report Forged Prescriptions Top 10 FDA & DEA Developments of 2022 — And Predictions for 2023 DEA Enforcement Update: Pharmacies Under Compliance Scrutiny for Their Handling of Controlled Substances Top 10 FDA & DEA Developments of 2021 — And Predictions for 2022 Top 10 Latest FDA & DEA Developments — And A Look Ahead to 2021 DEA Enforcement Update: Purdue Pharma, Red Flags, and Possible New Requirements for Handling Suspicious Orders DEA Enforcement Report: New Priorities and Strategies in Response to the Opioid Crisis DEA Compliance Manuals Chemical Handler’s Manual: A Guide to Chemical Control Regulations Revised 2013 Pharmacist’s Manual: An Informational Outline of the Controlled Substances Act Practitioner’s Manual: An Informational Outline of the Controlled Substances Act Drugs of Abuse: A DEA Resource Guide DEA Quotas User Manual (Jan. 10, 2017) DEA Forms Form 161 - Application for Permit to Export Controlled Substances Form 161r - Application for Permit to Export Controlled Substances for Subsequent Reexport Form 224 - New Application for Registration Form 107 - Reporting Theft or Loss of Listed Chemicals Form 486a - Import Declaration for Ephedrine, Pseudoephedrine, and Phenylpropanolamine Form 250 - Application for Procurement Quota Form 363 - Application for Registration Under Narcotic Addict Treatment Act Form 510 - Application for Registration Form 225 - Application for Registration Form 106 - Reporting Theft or Loss of Controlled Substances Form 486 - Import/Export Declaration for List I and List II Chemicals Form 222 - Order Form for Schedule I and II Controlled Substances Form 488 - Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine Form 236 - Import or Export Declaration Form 189 - Application for Individual Manufacturing Quota Form 41- Registrant's Record of Controlled Substances Destroyed DEA Policy Statements Interpretation and Clarification of Listing of Tetrahydrocannabinols in Schedule I Employee Screening Requirements: Dear Registrant Letter Frequently Asked Questions: Electronic Prescriptions of Controlled Substances Use of the Internet To Arrange International Sales of Listed Chemicals Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies Emergency Situations: Dear Practitioner Letter Dispensing Controlled Substances for the Treatment of Pain (2006) Statement of Principles on Industrial Hemp (2016) Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States (2016) Pharmaceutical Wastage: Dear Practitioner Letter (2014) Clarification of Existing Requirements for Prescribing Schedule II Controlled Substances Guidance Regarding Marijuana Enforcement (2013) Dispensing of Controlled Substances for the Treatment of Pain (2004) Coincident Activities for Researchers — Statement of Policy Laboratory Supply Special Surveillance List Distributions by Postal Service or Commercial Carriers to Nonregulated Persons Statement of Policy Regarding Dronabinol Production of Ecgonine in the United States: Statement of Policy Guidelines for Analytical Laboratories Conducting Analyses of Anonymous Samples DEA Schedules Exempt Prescription Products List List I and II Regulated Chemicals Consolidated List of Controlled Substances
Headquarters
1.800.677.3789